Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421
Source: Canadian Urological Association Journal - Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
More News: Brain | Canada Health | Incontinence | Neurology | Neurosurgery | Overactive Bladder | Overactive Bladder Syndrome | Pain | Study | Urology & Nephrology